There is no place for ovarian cancer screening in hereditary breast-ovarian cancer syndromes (in regard to "ESMO Clinical Practice Guideline on risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes")

被引：0
|
作者：
Sessa, C. [1 ]
Paluch-Shimon, S. [2 ,3 ]
机构：
[1] Oncol Inst Southern Switzerland IOSI, Med Oncol, Bellinzona, Switzerland
[2] Hadassah Univ Hosp, Sharett Inst Oncol Dept, Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷 / 01期
关键词：
D O I：
10.1016/j.annonc.2023.10.119
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：139 / 140
页数：2
相关论文
共 50 条
  • [21] Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer
    Bercow, Alexandra S.
    Eisenhauer, Eric L.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (05) : 864 - 872
  • [22] INSURANCE ADJUDICATION FAVORING PROPHYLACTIC SURGERY IN HEREDITARY BREAST-OVARIAN CANCER SYNDROME
    LYNCH, HT
    SEVERIN, MJ
    MOONEY, MJ
    LYNCH, J
    GYNECOLOGIC ONCOLOGY, 1995, 57 (01) : 23 - 26
  • [23] Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome
    Larissa I Batista
    Karen H Lu
    Elisabeth K Beahm
    Banu K Arun
    Diane C Bodurka
    Funda Meric-Bernstam
    BMC Cancer, 8
  • [24] Germline mutations of 4567 patients with hereditary breast-ovarian cancer spectrum in Thailand
    Chalermkiat Kansuttiviwat
    Pongtawat Lertwilaiwittaya
    Ekkapong Roothumnong
    Panee Nakthong
    Peerawat Dungort
    Chutima Meesamarnpong
    Warisara Tansa-Nga
    Khontawan Pongsuktavorn
    Supakit Wiboonthanasarn
    Warunya Tititumjariya
    Nannipa Phuphuripan
    Chittapat Lertbussarakam
    Jantanee Wattanarangsan
    Jiraporn Sritun
    Kittiporn Punuch
    Jirayu Kammarabutr
    Pornthira Mutirangura
    Wanna Thongnoppakhun
    Chanin Limwongse
    Manop Pithukpakorn
    npj Genomic Medicine, 9
  • [25] Germline mutations of 4567 patients with hereditary breast-ovarian cancer spectrum in Thailand
    Kansuttiviwat, Chalermkiat
    Lertwilaiwittaya, Pongtawat
    Roothumnong, Ekkapong
    Nakthong, Panee
    Dungort, Peerawat
    Meesamarnpong, Chutima
    Tansa-Nga, Warisara
    Pongsuktavorn, Khontawan
    Wiboonthanasarn, Supakit
    Tititumjariya, Warunya
    Phuphuripan, Nannipa
    Lertbussarakam, Chittapat
    Wattanarangsan, Jantanee
    Sritun, Jiraporn
    Punuch, Kittiporn
    Kammarabutr, Jirayu
    Mutirangura, Pornthira
    Thongnoppakhun, Wanna
    Limwongse, Chanin
    Pithukpakorn, Manop
    NPJ GENOMIC MEDICINE, 2024, 9 (01)
  • [26] Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome
    Batista, Larissa I.
    Lu, Karen H.
    Beahm, Elisabeth K.
    Arun, Banu K.
    Bodurka, Diane C.
    Meric-Bernstam, Funda
    BMC CANCER, 2008, 8 (1)
  • [27] Decision making and decision. support for hereditary breast-ovarian cancer susceptibility
    Schwartz, MD
    Peshkin, BN
    Valdimarsdottir, H
    Tercyak, KP
    Taylor, KL
    HEALTH PSYCHOLOGY, 2005, 24 (04) : S78 - S84
  • [28] Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
    Goshen, R
    Chu, W
    Elit, L
    Pal, T
    Hakimi, J
    Ackerman, I
    Fyles, A
    Mitchell, M
    Narod, SA
    GYNECOLOGIC ONCOLOGY, 2000, 79 (03) : 477 - 481
  • [29] Clinical and molecular diagnosis of inherited breast-ovarian cancer
    Chompret, A.
    IMAGERIE DE LA FEMME, 2005, 15 (1-2) : 76 - 92
  • [30] Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families
    Lynch, HT
    Snyder, C
    Lynch, JF
    Karatoprakli, P
    Trowonou, A
    Metcalfe, K
    Narod, SA
    Gong, G
    CANCER GENETICS AND CYTOGENETICS, 2006, 165 (02) : 91 - 97
12345